The $150,000 investment made in an East Lansing medical startup illustrates how a pre-seed capital fund created by the Michigan State Medical Society has started to adapt to the marketplace.
While there ultimately “is a number at some point” where directors at Perrigo Co. plc would have to consider selling, this spring’s $4.5 billion acquisition of a Belgian company positioned it with a greater ability to grow and remain independent, Chairman and CEO Joe Papa said today.
Mylan N.V. remains committed to acquiring Perrigo Co. plc and plans to present its case directly to shareholders, setting up a potential shareholder fight for control of the company.
The April index from Michael A. Dunlap & Associates registered a 56.80 on a scale of zero to 100. That compares to a 57.26 in January and a 57.58 six months ago. The April index was also the third best recorded since July 2007.
Refusing to take “no” for an answer, Mylan N.V. today raised its offer to acquire Perrigo Co. plc to nearly $32.7 billion — an offer that was quickly rejected.
After years of steadily rising rates for employee health coverage, small employers may finally get a little relief this year and next from the steep increases of the past.
Venture capital investing in Michigan got off to a strong start in 2014, as the amount invested in the first quarter reached the highest value in 15 years.
Eric Van Middendorp tapped a growing list of West Michigan-based health care, research and funding partners to develop a new medical device that secures patient breathing tubes. Through continued collaboration, the young inventor hopes to bring the product to market within the next two years.
Perrigo Co. plc this afternoon rejected a formal takeover from Mylan N.V. and urged its shareholders to do the same.
The Potters Field, England-based Mylan initiated a process under Irish takeover rules to formally offer Perrigo shareholders $60 in cash and 2.2 of Mylan’s ordinary shares for every share they hold, an offer that equates to around $30.0 billion.